Search research articles
Contact Us
Filters
Showing results (541-550 of 557) with videos related to
Page
of 56
Sort By:
Msphere
|
May 19, 2022
Ethnoracial Disparities in SARS-CoV-2 Seroprevalence in a Large Cohort of Individuals in Central North Carolina from April to December 2020
Cesar A Lopez, Clark H Cunningham, Sierra Pugh, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 5, 2008
5,6-Dihydro-1H-pyridin-2-ones as potent inhibitors of HCV NS5B polymerase
Frank Ruebsam, Chinh V Tran, Lian-Sheng Li, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
October 14, 2025
[Development, reliability, and validity of a treatment-related quality of life scale for Chinese patients with multiple myeloma]
C Y Sun, Z Cai, B Chen, et al.
Journal of Clinical Microbiology
|
July 21, 2021
Evaluation of Cell-Based and Surrogate SARS-CoV-2 Neutralization Assays
Anton M Sholukh, Andrew Fiore-Gartland, Emily S Ford, et al.
Biorxiv : the Preprint Server for Biology
|
August 15, 2020
<i>De novo</i> design of ACE2 protein decoys to neutralize SARS-CoV-2
Thomas W Linsky, Renan Vergara, Nuria Codina, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 20, 2016
Second primary malignancies in multiple myeloma: an overview and IMWG consensus
P Musto, K C Anderson, M Attal, et al.
Biorxiv : the Preprint Server for Biology
|
January 5, 2021
Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes in COVID-19 convalescent plasma
William N Voss, Yixuan J Hou, Nicole V Johnson, et al.
Cell
|
September 15, 2020
A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2
Ahmed O Hassan, Natasha M Kafai, Igor P Dmitriev, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 13, 2009
Discovery of tricyclic 5,6-dihydro-1H-pyridin-2-ones as novel, potent, and orally bioavailable inhibitors of HCV NS5B polymerase
Frank Ruebsam, Douglas E Murphy, Chinh V Tran, et al.
Leukemia
|
December 30, 2015
Management of relapsed multiple myeloma: recommendations of the International Myeloma Working Group
J Laubach, L Garderet, A Mahindra, et al.
Page
of 56
Search research articles
Search
Showing results (541-550 of 557) with videos related to
Sort By:
Page
of 56
Msphere
|
May 19, 2022
Ethnoracial Disparities in SARS-CoV-2 Seroprevalence in a Large Cohort of Individuals in Central North Carolina from April to December 2020
Cesar A Lopez, Clark H Cunningham, Sierra Pugh, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 5, 2008
5,6-Dihydro-1H-pyridin-2-ones as potent inhibitors of HCV NS5B polymerase
Frank Ruebsam, Chinh V Tran, Lian-Sheng Li, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
October 14, 2025
[Development, reliability, and validity of a treatment-related quality of life scale for Chinese patients with multiple myeloma]
C Y Sun, Z Cai, B Chen, et al.
Journal of Clinical Microbiology
|
July 21, 2021
Evaluation of Cell-Based and Surrogate SARS-CoV-2 Neutralization Assays
Anton M Sholukh, Andrew Fiore-Gartland, Emily S Ford, et al.
Biorxiv : the Preprint Server for Biology
|
August 15, 2020
<i>De novo</i> design of ACE2 protein decoys to neutralize SARS-CoV-2
Thomas W Linsky, Renan Vergara, Nuria Codina, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 20, 2016
Second primary malignancies in multiple myeloma: an overview and IMWG consensus
P Musto, K C Anderson, M Attal, et al.
Biorxiv : the Preprint Server for Biology
|
January 5, 2021
Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes in COVID-19 convalescent plasma
William N Voss, Yixuan J Hou, Nicole V Johnson, et al.
Cell
|
September 15, 2020
A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2
Ahmed O Hassan, Natasha M Kafai, Igor P Dmitriev, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 13, 2009
Discovery of tricyclic 5,6-dihydro-1H-pyridin-2-ones as novel, potent, and orally bioavailable inhibitors of HCV NS5B polymerase
Frank Ruebsam, Douglas E Murphy, Chinh V Tran, et al.
Leukemia
|
December 30, 2015
Management of relapsed multiple myeloma: recommendations of the International Myeloma Working Group
J Laubach, L Garderet, A Mahindra, et al.
Page
of 56